Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 35 Records) |
Query Trace: Attention and SLC6A2[original query] |
---|
Genome-wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2008 Dec 147B (8): 1345-54. Lasky-Su Jessica, Neale Benjamin M, Franke Barbara, Anney Richard J L, Zhou Kaixin, Maller Julian B, Vasquez Alejandro Arias, Chen Wai, Asherson Philip, Buitelaar Jan, Banaschewski Tobias, Ebstein Richard, Gill Michael, Miranda Ana, Mulas Fernando, Oades Robert D, Roeyers Herbert, Rothenberger Aribert, Sergeant Joseph, Sonuga-Barke Edmund, Steinhausen Hans Christoph, Taylor Eric, Daly Mark, Laird Nan, Lange Christoph, Faraone Stephen |
Functional gene variation in the human norepinephrine transporter: association with attention deficit hyperactivity disorder. Annals of the New York Academy of Sciences 2008 1129 256-60. Kim Chun-Hyung, Waldman Irwin D, Blakely Randy D, Kim Kwang-S |
Replication of a rare protective allele in the noradrenaline transporter gene and ADHD. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2008 Dec 147B (8): 1564-7. Xu X, Hawi Z, Brookes K J, Anney R, Bellgrove M, Franke B, Barry E, Chen W, Kuntsi J, Banaschewski T, Buitelaar J, Ebstein R, Fitzgerald M, Miranda A, Oades R D, Roeyers H, Rothenberger A, Sergeant J, Sonuga-Barke E, Steinhausen H-C, Faraone S V, Gill M, Asherson |
Candidate genes involved in neural plasticity and the risk for attention-deficit hyperactivity disorder: a meta-analysis of 8 common variants. Journal of psychiatry & neuroscience : JPN 2009 Sep 34 (5): 361-6. Forero Diego A, Arboleda Gonzalo H, Vasquez Rafael, Arboleda Humber |
Novel and functional norepinephrine transporter protein variants identified in attention-deficit hyperactivity disorder. Neuropharmacology 2009 Dec 57 (7-8): 694-701. Hahn Maureen K, Steele Angela, Couch R Steven, Stein Mark A, Krueger Jessica |
A haplotype of the norepinephrine transporter (Net) gene Slc6a2 is associated with clinical response to atomoxetine in attention-deficit hyperactivity disorder (ADHD). Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2009 Aug 34 (9): 2135-42. Ramoz Nicolas, Boni Claudette, Downing Anncatherine M, Close Sandra L, Peters Sandra L, Prokop Angela M, Allen Albert J, Hamon Michel, Purper-Ouakil Diane, Gorwood Phil |
Norepinephrine transporter gene (SLC6A2) is involved with methylphenidate response in Korean children with attention deficit hyperactivity disorder. International clinical psychopharmacology 2011 Mar 26 (2): 107-13. Song Jungeun, Song Dong-Ho, Jhung Kyungun, Cheon Keun- |
Possible association of norepinephrine transporter -3081(A/T) polymorphism with methylphenidate response in attention deficit hyperactivity disorder. Behavioral and brain functions : BBF 2010 6 57. Kim Boong-Nyun, Kim Jae-Won, Hong Soon Beom, Cho Soo-Churl, Shin Min-Sup, Yoo Hee-Jeo |
No evidence for association between a functional promoter variant of the Norepinephrine Transporter gene SLC6A2 and ADHD in a family-based sample. Attention deficit and hyperactivity disorders 2011 Sep 3 (3): 285-9. Renner T J, Nguyen T T, Romanos M, Walitza S, Röser C, Reif A, Schäfer H, Warnke A, Gerlach M, Lesch K |
Val/Val genotype of brain-derived neurotrophic factor (BDNF) Val66Met polymorphism is associated with a better response to OROS-MPH in Korean ADHD children. The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2011 Nov 14 (10): 1399-410. Kim Bung-Nyun, Cummins Tarrant D R, Kim Jae-Won, Bellgrove Mark A, Hong Soon-Beom, Song Sook-Hyung, Shin Min-Sup, Cho Soo-Churl, Kim Ji-Hoon, Son Jung-Woo, Shin Yun-Mi, Chung Un-Sun, Han Doug-Hy |
Norepinephrine transporter -3081(A/T) and alpha-2A-adrenergic receptor MspI polymorphisms are associated with cardiovascular side effects of OROS-methylphenidate treatment. Journal of psychopharmacology (Oxford, England) 2012 Mar 26 (3): 380-9. Cho Soo-Churl, Kim Bung-Nyun, Cummins Tarrant D R, Kim Jae-Won, Bellgrove Mark |
Possible effect of norepinephrine transporter polymorphisms on methylphenidate-induced changes in neuropsychological function in attention-deficit hyperactivity disorder. Behavioral and brain functions : BBF 2012 8 (1): 22. Park Subin, Kim Jae-Won, Yang Young-Hui, Hong Soon-Beom, Park Min-Hyeon, Kim Boong-Nyun, Shin Min-Sup, Yoo Hee-Jeong, Cho Soo-Chu |
Differential association between the norepinephrine transporter gene and ADHD: role of sex and subtype. Journal of psychiatry & neuroscience : JPN 2012 Feb 37 (2): 129-37. Sengupta Sarojini M, Grizenko Natalie, Thakur Geeta A, Bellingham Johanne, DeGuzman Rosherrie, Robinson Sandra, TerStepanian Marina, Poloskia Anna, Shaheen S M, Fortier Marie-Eve, Choudhry Zia, Joober Rid |
Adrenergic neurotransmitter system transporter and receptor genes associated with atomoxetine response in attention-deficit hyperactivity disorder children. Journal of neural transmission (Vienna, Austria : 1996) 2012 Dec . Yang L, Qian Q, Liu L, Li H, Faraone SV, Wang Y |
Comprehensive phenotype/genotype analyses of the norepinephrine transporter gene (SLC6A2) in ADHD: relation to maternal smoking during pregnancy. PloS one 2012 7 (11): 11. Thakur GA, Sengupta SM, Grizenko N, Choudhry Z, Joober R |
A high density linkage disequilibrium mapping in 14 noradrenergic genes: evidence of association between SLC6A2, ADRA1B and ADHD. Psychopharmacology 2013 Feb 225 (4): 895-902. Hawi Ziarih, Matthews Natasha, Barry Edwina, Kirley Aiveen, Wagner Joseph, Wallace Robyn H, Heussler Helen S, Vance Alasdair, Gill Michael, Bellgrove Mark |
Norepinephrine genes predict response time variability and methylphenidate-induced changes in neuropsychological function in attention deficit hyperactivity disorder. Journal of clinical psychopharmacology 2013 Jun 33 (3): 356-62. Kim Bung-Nyun, Kim Jae-Won, Cummins Tarrant D R, Bellgrove Mark A, Hawi Ziarih, Hong Soon-Beom, Yang Young-Hui, Kim Hyo-Jin, Shin Min-Sup, Cho Soo-Churl, Kim Ji-Hoon, Son Jung-Woo, Shin Yun-Mi, Chung Un-Sun, Han Doug-Hy |
Methylphenidate side effect profile is influenced by genetic variation in the attention-deficit/hyperactivity disorder-associated CES1 gene. Journal of child and adolescent psychopharmacology 2013 Dec 23 (10): 655-64. Johnson Katherine A, Barry Edwina, Lambert David, Fitzgerald Michael, McNicholas Fiona, Kirley Aiveen, Gill Michael, Bellgrove Mark A, Hawi Ziar |
No association of the norepinephrine transporter gene (SLC6A2) and cognitive and behavioural phenotypes of patients with autism spectrum disorder. European archives of psychiatry and clinical neuroscience 2014 Sep 264 (6): 507-15. Park Subin, Park Jong-Eun, Cho Soo-Churl, Kim Bung-Nyun, Shin Min-Sup, Kim Jae-Won, Cho In Hee, Kim Soon Ae, Park Mira, Park Tae-Won, Son Jung-Woo, Chung Un-Sun, Yoo Hee Jeo |
A haplotype of the norepinephrine transporter gene (SLC6A2) is associated with visual memory in attention-deficit/hyperactivity disorder. Progress in neuro-psychopharmacology & biological psychiatry 2015 Apr 58 89-96. Shang Chi-Yung, Chiang Huey-Ling, Gau Susan Shur-F |
Testing for the mediating role of endophenotypes using molecular genetic data in a twin study of ADHD traits. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2016 May . Pinto Rebecca, Asherson Philip, Ilott Nicholas, Cheung Celeste H M, Kuntsi Jon |
Association of norepinephrine transporter gene polymorphisms in attention-deficit/hyperactivity disorder in Korean population. Progress in neuro-psychopharmacology & biological psychiatry 2016 Oct . Oh So-Young, Kim Yong- |
Attention deficit hyperactivity disorder: genetic association study in a cohort of Spanish children. Behavioral and brain functions : BBF 2016 12 (1): 2. Gomez-Sanchez Clara I, Riveiro-Alvarez Rosa, Soto-Insuga Victor, Rodrigo Maria, Tirado-Requero Pilar, Mahillo-Fernandez Ignacio, Abad-Santos Francisco, Carballo Juan J, Dal-Ré Rafael, Ayuso Carm |
No genetic association between attention-deficit/hyperactivity disorder (ADHD) and Parkinson's disease in nine ADHD candidate SNPs. Attention deficit and hyperactivity disorders 2017 Feb . Geissler Julia M, , Romanos Marcel, Gerlach Manfred, Berg Daniela, Schulte Claud |
Pharmacogenetics predictors of methylphenidate efficacy in childhood ADHD. Molecular psychiatry 2017 Dec . Myer N M, Boland J R, Faraone S |
Association analysis of norepinephrine transporter polymorphisms and methylphenidate response in ADHD patients. Progress in neuro-psychopharmacology & biological psychiatry 2018 06 84 (Pt A): 122-128. Angyal Nora, Horvath Erzsebet Zsofia, Tarnok Zsanett, Richman Mara J, Bognar Emese, Lakatos Krisztina, Sasvari-Szekely Maria, Nemoda Zsof |
Genetic Variation Underpinning ADHD Risk in a Caribbean Community. Cells 2019 Aug 8 (8): . Puentes-Rozo Pedro J, Acosta-López Johan E, Cervantes-Henríquez Martha L, Martínez-Banfi Martha L, Mejia-Segura Elsy, Sánchez-Rojas Manuel, Anaya-Romero Marco E, Acosta-Hoyos Antonio, García-Llinás Guisselle A, Mastronardi Claudio A, Pineda David A, Castellanos F Xavier, Arcos-Burgos Mauricio, Vélez Jorge |
The norepinephrine transporter gene modulates intrinsic brain activity, visual memory, and visual attention in children with attention-deficit/hyperactivity disorder. Molecular psychiatry 2019 10 26 (8): 4026-4035. Shang Chi-Yung, Lin Hsiang-Yuan, Gau Susan Shur-F |
Differential Genetic Effect of the Norepinephrine Transporter Promoter Polymorphisms on Attention Problems in Clinical and Non-clinical Samples. Frontiers in neuroscience 2018 12 1051. Nemoda Zsofia, Angyal Nora, Tarnok Zsanett, Birkas Emma, Bognar Emese, Sasvari-Szekely Maria, Gervai Judit, Lakatos Kriszti |
CES1 and SLC6A2 Genetic Variants As Predictors of Response To Methylphenidate in Autism Spectrum Disorders. Pharmacogenomics and personalized medicine 2022 11 15 951-957. Hernandez Marta H, Bote Valentin, Serra-LLovich Alexandre, Cendros Marc, Salazar Juliana, Mestres Conxita, Guijarro Silvina, Alvarez Aida, Lamborena Cristina, Mendez Iria, Sanchez Bernardo, Hervas Amaia, Arranz Maria |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: